@article{013be0b7f5054d99afe2438473265ca0,
title = "Newer Methods for Ventricular Tachycardia Ablation and When to Use Them",
author = "Stevenson, {William G.} and Sapp, {John L.}",
note = "Funding Information: Dr Stevenson has received speaking honoraria from Abbott Medical; Boston Scientific, Inc.; Johnson and Johnson; Biotronik; and Medtronic, Inc; and consulting fees from Abiomed. He has received research funding from Thermedical. Dr Sapp has received research grants and honoraria from Biosense Webster and Abbott Medical, Inc. and honoraria from Medtronic, Inc. Dr Stevenson is co-holder of US patent #7207989 “Method for Ablating With Needle Electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date, no royalties have been received. Dr Sapp is co-holder of US patent #7207989 “Method for Ablating With Needle Electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date, no royalties have been received. Publisher Copyright: {\textcopyright} 2021 Canadian Cardiovascular Society",
year = "2022",
month = apr,
doi = "10.1016/j.cjca.2021.12.004",
language = "English",
volume = "38",
pages = "502--514",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "4",
}